Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anika Therapeutics

11.27
-0.5100-4.33%
Post-market: 11.270.00000.00%16:04 EDT
Volume:76.05K
Turnover:857.17K
Market Cap:161.63M
PE:-2.90
High:11.65
Open:11.65
Low:11.10
Close:11.78
Loading ...

B. Riley Initiates Anika Therapeutics at Buy With $21 Price Target

MT Newswires Live
·
17 Apr

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
08 Apr

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
08 Apr

Are Options Traders Betting on a Big Move in Anika Therapeutics (ANIK) Stock?

Zacks
·
03 Apr

Anika Therapeutics Faces Financial Strain Amid Geopolitical Tensions and Supply Chain Disruptions

TIPRANKS
·
18 Mar

Anika Therapeutics Full Year 2024 Earnings: Misses Expectations

Simply Wall St.
·
14 Mar

Anika Therapeutics Is Maintained at Outperform by Barrington Research

Dow Jones
·
13 Mar

Q4 2024 Anika Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
13 Mar

US Stocks Likely To Open Lower After A Brief Respite: 'Add Exposure To Equities' Amid Pullback, Says Expert

Benzinga
·
13 Mar

Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges

GuruFocus.com
·
13 Mar

Anika Therapeutics Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
11 Mar

BUZZ-Anika Therapeutics falls after its completes divestiture of Parcus Medical business

Reuters
·
08 Mar

Analysts Offer Insights on Healthcare Companies: Myomo (MYO), Kymera Therapeutics (KYMR) and Anika Therapeutics (ANIK)

TIPRANKS
·
07 Mar

Anika Therapeutics Completes Divestiture of Parcus Medical to Medacta

MT Newswires Live
·
07 Mar

Anika Completes Divestiture of Parcus Medical

THOMSON REUTERS
·
07 Mar

Anika Completes Divestiture of Parcus Medical

GlobeNewswire
·
07 Mar

Is Anika Therapeutics, Inc. (ANIK) the Best Small Cap Pharma Stocks to Buy Now?

Insider Monkey
·
01 Mar

Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025

GlobeNewswire
·
26 Feb

Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference

GlobeNewswire
·
25 Feb

Strength Seen in Stoke Therapeutics (STOK): Can Its 9.4% Jump Turn into More Strength?

Zacks
·
05 Feb